WCM
Wedge Capital Management Portfolio holdings
AUM
$5.6B
This Quarter Return
+1.96%
1 Year Return
+23.19%
3 Year Return
+97.17%
5 Year Return
+207.91%
10 Year Return
+330.87%
AUM
$5.55B
AUM Growth
+$5.55B
(-4.1%)
Cap. Flow
-$139M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
12.38%
Holding
532
New
34
Increased
142
Reduced
302
Closed
24
Top Buys
| 1 |
Northrop Grumman
NOC
|
$66.2M |
| 2 |
Cisco
CSCO
|
$65.8M |
| 3 |
Fabrinet
FN
|
$63.2M |
| 4 |
Brinker International
EAT
|
$50.6M |
| 5 |
Arista Networks
ANET
|
$50.5M |
Top Sells
| 1 |
Lam Research
LRCX
|
$59.9M |
| 2 |
TransDigm Group
TDG
|
$59.9M |
| 3 |
Textron
TXT
|
$57.2M |
| 4 |
Qualcomm
QCOM
|
$54.1M |
| 5 |
Applied Materials
AMAT
|
$49.6M |
Sector Composition
| 1 | Technology | 25.27% |
| 2 | Financials | 16.45% |
| 3 | Consumer Discretionary | 15.73% |
| 4 | Industrials | 12.72% |
| 5 | Healthcare | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Synovus
SNV
$7.16B
| $36.8M | 0.66% | 717,432 -126,452 | -15% | -$6.48M |
|
52
Zions Bancorporation
ZION
$8.56B
| $36.7M | 0.66% | 675,944 -127,519 | -16% | -$6.92M |
|
53
MetLife
MET
$54.1B
| $35.9M | 0.65% | 439,056 -64,877 | -13% | -$5.31M |
|
54
Hartford Financial Services
HIG
$37.2B
| $35.4M | 0.64% | 323,520 -12,753 | -4% | -$1.4M |
|
55
Prudential Financial
PRU
$38.6B
| $35.3M | 0.64% | 297,583 -24,469 | -8% | -$2.9M |
|
56
Jackson Financial
JXN
$6.88B
| $35.2M | 0.63% | 403,871 -43,300 | -10% | -$3.77M |
|
57
Fidelity National Financial
FNF
$16.3B
| $35.1M | 0.63% | 625,000 -26,708 | -4% | -$1.5M |
|
58
HCA Healthcare
HCA
$94.5B
| $34.8M | 0.63% | 116,075 +8,329 | +8% | +$2.5M |
|
59
Cigna
CI
$80.3B
| $34.5M | 0.62% | 125,066 +11,636 | +10% | +$3.21M |
|
60
DaVita
DVA
$9.85B
| $33.2M | 0.6% | 222,007 -16,487 | -7% | -$2.47M |
|
61
Hologic
HOLX
$14.9B
| $32.9M | 0.59% | 457,039 +185 | +0% | +$13.3K |
|
62
Post Holdings
POST
$6.15B
| $30.1M | 0.54% | 263,268 -31,253 | -11% | -$3.58M |
|
63
Tenet Healthcare
THC
$16.3B
| $30.1M | 0.54% | 238,465 +7,112 | +3% | +$898K |
|
64
Jazz Pharmaceuticals
JAZZ
$7.75B
| $29.9M | 0.54% | 243,005 -48,679 | -17% | -$5.99M |
|
65
Molson Coors Class B
TAP
$9.98B
| $29.9M | 0.54% | 521,970 -126,734 | -20% | -$7.26M |
|
66
Pfizer
PFE
$141B
| $29.2M | 0.53% | 1,101,225 -13,976 | -1% | -$371K |
|
67
Bristol-Myers Squibb
BMY
$96B
| $29.2M | 0.52% | 515,398 -122,924 | -19% | -$6.95M |
|
68
Gilead Sciences
GILD
$140B
| $28.9M | 0.52% | 313,225 -86,409 | -22% | -$7.98M |
|
69
Bio-Rad Laboratories Class A
BIO
$8.06B
| $28.7M | 0.52% | +87,487 | New | +$28.7M |
|
70
Labcorp
LH
$23.1B
| $28.7M | 0.52% | 125,100 -17,868 | -12% | -$4.1M |
|
71
Cardinal Health
CAH
$35.5B
| $28.6M | 0.51% | 241,768 -37,092 | -13% | -$4.39M |
|
72
AbbVie
ABBV
$372B
| $28.6M | 0.51% | 160,799 -3,753 | -2% | -$667K |
|
73
Centene
CNC
$14.3B
| $28.6M | 0.51% | 471,627 +55,475 | +13% | +$3.36M |
|
74
Molina Healthcare
MOH
$9.8B
| $28.4M | 0.51% | 97,505 +4,683 | +5% | +$1.36M |
|
75
Philip Morris
PM
$260B
| $28.2M | 0.51% | 234,588 -19,052 | -8% | -$2.29M |
|